On Nov. 1, 2001, the U.S. Senate's Committee on Health, Education, Labor, and Pensions passed a measure aimed at bolstering research and education on blood cancers.

The committee unanimously approved a bill that would order the National Institutes of Health to establish a program to research leukemia, multiple myeloma, and other hematologic malignancies. The proposal authorizes $250 million for the effort and gives another $25 million for a national education campaign on blood cancers.

The bill is known as the Hematological Cancer Research Investment and Education Act of 2001. It is Senate bill number S1094, of the 107th Congress.

The bill would "amend the Public Health Service Act to provide for research, information, and education with respect to blood cancer."

IN THE SENATE OF THE UNITED STATES

June 22, 2001

Mrs. HUTCHISON (for herself, Ms. MIKULSKI, Mrs. MURRAY, and Mr. INOUYE) introduced the following bill; which was read twice and referred to the Committee on Health, Education, Labor, and Pensions

--------------------------------------------------------------------------------

A BILL

To amend the Public Health Service Act to provide for research, information, and education with respect to blood cancer.

Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

This Act may be cited as the "Hematological Cancer Research Investment and Education Act of 2001."

SEC. 2. FINDINGS.

Congress finds that:

(1) An estimated 109,500 people in the United States will be diagnosed with leukemia, lymphoma, and multiple myeloma in 2001.

(2) New cases of the blood cancers described in paragraph (1) account for 8.6 percent of new cancer cases.

(3) Those devastating blood cancers will cause the deaths of an estimated 60,300 persons in the United States in 2001. Every 9 minutes, a person in the United States dies from leukemia, lymphoma, or multiple myeloma.

(4) While less than 5 percent of Federal funds for cancer research are spent on those blood cancers, those blood cancers cause 11 percent of all cancer deaths in the United States.

(5) Increased Federal support of research into leukemia, lymphoma, and multiple myeloma has resulted and will continue to result in significant advances in the early detection, the treatment, and ultimately the cure of those blood cancers.

SEC. 3. RESEARCH, INFORMATION, AND EDUCATION WITH RESPECT TO BLOOD CANCER.

(a) RESEARCH — Part B of title IV of the Public Health Service Act (42 U.S.C. 284 et seq.) is amended by adding at the end the following:

SEC. 409I. RESEARCH, INFORMATION, AND EDUCATION WITH RESPECT TO BLOOD CANCER.

(a) RESEARCH -

(1) SUBJECT - The Director of the National Institutes of Health shall establish and carry out a program for the conduct and support of research with respect to blood cancer , and particularly with respect to leukemia, lymphoma, and multiple myeloma.

(2) ADMINISTRATION - The Director of the National Institutes of Health shall carry out this subsection through the Director of the National Cancer Institute and in collaboration with any other agencies that the Director of the National Institutes of Health determines to be appropriate.

(3) AUTHORIZATION OF APPROPRIATIONS - There is authorized to be appropriated to carry out this subsection $250,000,000 for fiscal year 2002 and each subsequent fiscal year.

(b) INFORMATION AND EDUCATION -

(1) SUBJECT - The Director of the Centers for Disease Control and Prevention shall establish and carry out a program to provide information and education for the general public with respect to blood cancer , and particularly with respect to leukemia, lymphoma, and multiple myeloma.

(2) AUTHORIZATION OF APPROPRIATIONS - There is authorized to be appropriated to carry out this subsection $25,000,000 for fiscal year 2002 and each subsequent fiscal year..

Source: U.S. Senate

Give me a holler

CMLSupport Home Page

This site was last updated on Nov. 3, 2001

Copyright © 2000-2001 CMLSupport.com. All rights reserved.

The fine print: These contents may not be reproduced in whole or in part without the express written permission of the author. Or she will beat you up and stuff. This site is best viewed with Internet Explorer, but we won't stop you from using another Web browser. Congratulations if you've read all of this! (But we're sorry to say, the person before you got our last cash prize!)